Vikas Dukhande

Vikas Dukhande

St John's University

H-index: 16

Asia-Taiwan

About Vikas Dukhande

Vikas Dukhande, With an exceptional h-index of 16 and a recent h-index of 13 (since 2020), a distinguished researcher at St John's University, specializes in the field of Diabetes, Cell death, Cancer metabolism, Ubiquitination, Lafora disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells

Mechanistic Investigation of a Combination of a Cell Cycle Inhibitor and an HDAC Inhibitor in Pancreatic Cancer Cells

Metabolic Rewiring and Mechanism of Action of an Antiepileptic Drug Repurposed for its Potential in Glioblastoma

Evaluation of a Combination of an HDAC Inhibitor and a Cell Cycle Inhibitor in Pancreatic Cancer Cells

Mechanistic Elucidation of an Anti-Epileptic for the Treatment of Glioblastoma

Mass Spectrometry‐based Proteomics in Deciphering Hormonal Regulation of Ubiquitin Linkages

Recent advances in the application of nanomedicine for the treatment of diabetes

Repurposing an antiepileptic drug for the treatment of glioblastoma

Vikas Dukhande Information

University

Position

Pharmaceutical Sciences College of Pharmacy and Health Sciences

Citations(all)

1100

Citations(since 2020)

564

Cited By

676

hIndex(all)

16

hIndex(since 2020)

13

i10Index(all)

24

i10Index(since 2020)

16

Email

University Profile Page

St John's University

Google Scholar

View Google Scholar Profile

Vikas Dukhande Skills & Research Interests

Diabetes

Cell death

Cancer metabolism

Ubiquitination

Lafora disease

Top articles of Vikas Dukhande

Title

Journal

Author(s)

Publication Date

The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells

Life Sciences

Hari Priya Vemana

Vikas V Dukhande

2023/9/15

Mechanistic Investigation of a Combination of a Cell Cycle Inhibitor and an HDAC Inhibitor in Pancreatic Cancer Cells

Shraddha Bhutkar

Anjali Yadav

Vikas Dukhande

2023/6/1

Metabolic Rewiring and Mechanism of Action of an Antiepileptic Drug Repurposed for its Potential in Glioblastoma

Anjali Yadav

Shraddha Bhutkar

Vikas Dukhande

2023/6/1

Evaluation of a Combination of an HDAC Inhibitor and a Cell Cycle Inhibitor in Pancreatic Cancer Cells

The FASEB Journal

Shraddha P Bhutkar

Anjali Yadav

Vikas V Dukhande

2022/5

Mechanistic Elucidation of an Anti-Epileptic for the Treatment of Glioblastoma

FASEB journal: official publication of the Federation of American Societies for Experimental Biology

Anjali Yadav

Ali Alnakhli

Hari Priya Vemana

Shraddha Bhutkar

Shrikant Barot

...

2022/5

Mass Spectrometry‐based Proteomics in Deciphering Hormonal Regulation of Ubiquitin Linkages

The FASEB Journal

Hari Priya Vemana

Ehab M Abo‐Ali

Rinat Abzalimov

Vikas V Dukhande

2022/5

Recent advances in the application of nanomedicine for the treatment of diabetes

Hari Priya Vemana

Vikas V Dukhande

2022/1

Repurposing an antiepileptic drug for the treatment of glioblastoma

Pharmaceutical research

Anjali Yadav

Ali Alnakhli

Hari Priya Vemana

Shraddha Bhutkar

Aaron Muth

...

2022/11

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy

Heliyon

Aishwarya Saraswat

Hari Priya Vemana

Vikas V Dukhande

Ketan Patel

2022/1/1

Metabolic alterations and mitochondrial dysfunction underlie hepatocellular carcinoma cell death induced by a glycogen metabolic inhibitor

Biochemical pharmacology

Shrikant Barot

Olivia J Stephenson

Hari Priya Vemana

Anjali Yadav

Shraddha Bhutkar

...

2022/9/1

In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells

Experimental cell research

Manali Patki

Aishwarya Saraswat

Shraddha Bhutkar

Vikas Dukhande

Ketan Patel

2021/8/15

Development of dual ARV-825 and nintedanib-loaded PEGylated nano-liposomes for synergistic efficacy in vemurafnib-resistant melanoma

Pharmaceutics

Yige Fu

Aishwarya Saraswat

Zenghui Wei

Manas Yogendra Agrawal

Vikas V Dukhande

...

2021/7/1

Combination of gemcitabine and cytidine deaminase inhibitor: A breakthrough cocktail for the treatment of pancreatic ductal adenocarcinoma

Cancer Research

Manali Patki

Aishwarya Saraswat

Shraddha Bhutkar

Vikas Dukhande

Ketankumar Patel

2021/7/1

Designing of DLinDMA‐Anchored Liposomal Carrier for Gene Therapy of Rare Genetic Lafora Disease

The FASEB Journal

Hari Priya Vemana

Aishwarya Saraswat

Shraddha Bhutkar

Ketan Patel

Vikas Dukhande

2021/5

A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes

Nanomedicine

Hari Priya Vemana

Aishwarya Saraswat

Shraddha Bhutkar

Ketan Patel

Vikas V Dukhande

2021/3

Methods for studying TNFα-induced autophagy

Immune Mediators in Cancer: Methods and Protocols

Sheyda Najafi

Ehab M Abo-Ali

Vikas V Dukhande

2020

Nanoformulation of PROteolysis TArgeting Chimera targeting ‘undruggable’ c-Myc for the treatment of pancreatic cancer

Nanomedicine

Aishwarya Saraswat

Manali Patki

Yige Fu

Shrikant Barot

Vikas V Dukhande

...

2020/8

Malin, an E3 Ubiquitin Ligase, Modulates glycogen metabolism in multiple cellular compartments

The FASEB Journal

Matthew Gentry

Ramon C Sun

Vikas V Dukhande

Zhengqui Zhou

Lyndsay E Young

...

2020/4

Hormonal Regulation of Novel Glycogen Metabolic Proteins Hari Priya Vemana, Ehab M. Abo‐Ali, John L. Croft, Shraddha Bhutkar, Michael Woolford, Vikas V. DukhandeDepartment of …

The FASEB Journal

Hari Priya Vemana

Ehab M Abo-Ali

John L Croft

Shradda Bhutkar

Michael Woolford

...

2020/4

Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity

Bioorganic & Medicinal Chemistry Letters

Dipti Kanabar

Pamela Farrales

Manu Gnanamony

Joseph Almasri

Ehab M Abo-Ali

...

2020/2/15

See List of Professors in Vikas Dukhande University(St John's University)